Academic Highlights October 31, 2008

International Consensus Group on the Evidence-Based Pharmacologic Treatment of Bipolar I and II Depression

Siegfried Kasper, M.D.; Joseph R. Calabrese, M.D.; Gordon Johnson, M.B.B.S.; Osamu Tajima, Ph.D.; Eduard Vieta, M.D., Ph.D.; Adele C. Viguera, M.D.; Lakshmi N. Yatham, M.B.B.S., F.R.C.P.C.; Allan H. Young, M.D., F.R.C.Psych

J Clin Psychiatry 2008;69(10):1632-1646

Article Abstract

Click to enlarge page

In 2004, an International Consensus Group (ICG) developed and published recommendations for the treatment of bipolar I depression based on available clinical evidence. The ICG reconvened in October 2007 to reevaluate clinical trial data published in the intervening years on the treatment of bipolar I depression. In addition, the ICG extended the scope of its discussions to consider published evidence for the treatment of bipolar II depression and also special populations of patients with bipolar depression.

Â